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ABSTRACT 23 
Creatine/phosphorylcreatine (PCr) responses to creatine supplementation may be modulated 24 
by age, diet and tissue, but studies assessing this possibility are lacking. Therefore, we aimed 25 
to determine whether the PCr responses vary as a function of age, diet, and tissue. Fifteen 26 
children, 17 omnivorous and 14 vegetarian adults, and 18 elderly participated in this study. 27 
Participants were given placebo and subsequently creatine (0.3 g·kg-1·day-1) for 7 days in a 28 
single-blind fashion. PCr was measured through phosphorus magnetic resonance 29 
spectroscopy (31P-MRS) in muscle and brain. Creatine supplementation increased muscle PCr 30 
in children (p<0.0003) and elderly (p<0.001), whereas the increase in omnivores did not 31 
reach statistical significant difference (p=0.3348). Elderly had greater PCr increases than 32 
children and omnivores (p<0.0001 for both), whereas children experienced greater PCr 33 
increases than omnivores (p=0.0022). In relation to diet, vegetarians (p<0.0001), but not 34 
omnivores, had significant increases in muscle PCr content. Brain PCr content was not 35 
affected by creatine supplementation in any group, and delta changes in brain PCr (-0.7 to 36 
+3.9%) were inferior than muscle PCr content (+10.3 to +27.6%; p<0.0001 for all 37 
comparisons). PCr responses to a standardized creatine protocol (0.3 g·kg-1·day-1 for 7 days) 38 
may be affected by age, diet and tissue. While creatine supplementation was able to increase 39 
muscle PCr in all groups, although to different extents, brain PCr was shown to be 40 
unresponsive overall. These findings demonstrate the need to tailor creatine protocols to 41 
optimise creatine/PCr accumulation both in muscle and in brain, enabling a better 42 
appreciation of the pleiotropic properties of creatine.  43 
 44 
KEY-WORDS: phosphorylcreatine, skeletal muscle, brain, children, elderly, adults. 45 
46 
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INTRODUCTION 47 
Creatine supplementation has long been used in sport, although its use in clinical 48 
settings has increased in the last years (4, 15, 17). There is compelling evidence showing that 49 
creatine can improve high-intensive exercise capacity and lean body mass in recreationally 50 
trained individuals and athletes (13, 15, 45). Additionally, the therapeutic application of 51 
creatine has been a topic of increasing interest (13, 15, 50). In this context, there is evidence 52 
that creatine supplementation, particularly along with exercise training, partially offsets 53 
physical disabilities in elderly individuals as well as in pediatric and adult patients suffering 54 
from muscle weakness/wasting diseases (13, 14, 41). 55 
 Recently, growing attention has also been given to the potential therapeutic role of 56 
creatine in diseases characterized by brain bioenergetics dysfunction, such as 57 
neurodegenerative and psychiatric disorders (20, 23, 24). In such conditions, creatine is 58 
believed to optimize brain energy provision, ultimately rescuing brain energy homeostasis, 59 
thereby improving disease-related symptoms (6, 25, 35). It has been proposed that the central 60 
mechanism by which creatine exerts its physiological effects is through increased tissue 61 
creatine/phosphorylcreatine (PCr) content, thereby enhancing ATP re-synthesis via PCr 62 
degradation (51).  63 
Harris et al., (17) were the first to show that creatine supplementation is able to 64 
increase total muscle creatine content (i.e., free creatine plus PCr) by approximately 20% in 65 
young healthy individuals. The most effective protocol used in this seminal study (~0.3 g·kg-66 
1·day-1 for 5-7 days), commonly referred to as “creatine loading”, has been frequently applied 67 
to other populations (e.g., diseased individuals, children, elderly) in an attempt to increase 68 
muscle creatine (9, 10, 32, 33, 37), or even brain creatine content (25, 31, 49). However, it is 69 
not fully understood whether age (children vs. adults vs. elderly) and tissue (brain vs. muscle) 70 
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are factors influencing the responsiveness to creatine supplementation. In fact, there is 71 
evidence suggesting that elderly and adults may experience distinct increases in muscle 72 
creatine/PCr content following supplementation (8, 30), although conflicting results exist (21, 73 
33). There is no study examining the effects of creatine supplementation on muscle 74 
creatine/PCr accretion in healthy children, hence no direct comparison between children, 75 
adults and elderly has been possible so far, precluding any firm conclusion regarding the role 76 
of age on creatine accumulation. In relation to tissue, greater doses of creatine seem to be 77 
necessary to yield brain creatine/PCr accretion in comparison to those used for muscle 78 
loading (46). However, studies directly assessing the differences between brain and muscle 79 
creatine/PCr accumulation after a standardized creatine protocol are currently lacking.  80 
 Another unsolved question is whether (and, if so, to what extent) diet behavior can 81 
affect creatine/PCr accumulation in response to creatine loading. From a muscle perspective, 82 
data suggest that low meat eaters (who normally show reduced creatine/PCr content) 83 
experience greater creatine/PCr accretion following supplementation (17). Nonetheless, the 84 
influence of diet on brain creatine/PCr remains essentially unknown. One solitary study 85 
showed similar brain creatine content between vegetarians and omnivores (38); however, 86 
there is no study comparing brain creatine/PCr responses to creatine supplementation in these 87 
populations.  88 
 Since most studies that have examined the ergogenic or therapeutic effects of creatine 89 
supplementation did not measure tissue creatine/PCr to confirm the efficacy of 90 
supplementation, it is possible that “negative” outcomes arising from these studies could be 91 
due to the inability of the supplementation regime to increase tissue creatine/PCr content. 92 
Therefore, we aimed to expand the knowledge on fundamental questions related to responses 93 
to creatine supplementation by comprehensively investigating the role of age, tissue and diet 94 
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on PCr accumulation following a standardized creatine regimen (relative to individual body 95 
mass).     96 
 97 
MATERIALS AND METHODS 98 
Participants  99 
Fifteen prepubescent children (10 to 12 years), 17 omnivorous and 14 vegetarian 100 
adults (18 to 45 years) and 18 elderly individuals (62 to 84 years) from both sexes took part 101 
in this investigation. The main characteristics of the participants are shown in Table 1. 102 
General exclusion criteria were as follows: 1) cognitive and psychiatric disorders, 103 
skeletal muscle disturbances or any other disease that could potentially affect creatine 104 
metabolism; 2) vegetarian diet for children and elderly; 3) previous use of creatine 105 
supplementation; 4) current pregnancy; 5) pacemaker or metal prosthesis that preclude MRS 106 
assessment.   107 
Vegetarians had been on a vegetarian diet for at least 1 year (10.2 ± 9.8 years); they 108 
were self-identified as lacto-ovo-vegetarians (n=9), ovo-vegetarians (n=1) or vegans (n=4). 109 
To ensure an accurate self-classification, all of the subjects were provided with a 110 
comprehensive explanation on the definitions regarding vegetarianism and its sub-111 
classifications, according to previously reported criteria (48). No statistical differences 112 
between vegetarians and omnivores were shown for any main characteristics, except for 113 
dietary intake, especially creatine, as expected.   114 
The study was approved by the local Ethical Committee (School of Medicine, 115 
University of São Paulo). All subjects (and their legal guardians, in case of children) signed 116 
the written informed consent. The experimental procedures were in accordance with the 117 
Helsinki Declaration revised in 2008. 118 
 119 
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Experimental Design 120 
The participants were given placebo and subsequently creatine for 7 days in a single-121 
blind fashion. PCr was measured through phosphorus magnetic resonance spectroscopy (31P-122 
MRS) in muscle and brain at baseline (i.e., no supplementation) and after both placebo and 123 
creatine arms. Baseline and placebo measures were used to calculate the coefficient of 124 
variation (CV) for PCr values. Figure 1 illustrates our research questions (i.e., influence of 125 
age, diet and tissue on creatine response) and the experimental design.  126 
At baseline, the participants were assessed for BMI, maturational status according to 127 
Marshal and Tanner (26) (only children), and physical activity level using the short-version 128 
of the International Physical Activity Level Questionnaire (IPAQ) (22). Dietary intake was 129 
assessed by 3 non-consecutive 24-h dietary recalls at baseline and during each arm. Energy, 130 
carbohydrate, lipids and protein intake were analyzed using the software Avanutri (Rio de 131 
Janeiro, Brazil) and creatine intake was estimated based on specific food composition tables 132 
(16, 19). All participants were asked to maintain their dietary intake and physical activity 133 
levels throughout the experimental intervention.  134 
 135 
Creatine supplementation protocol and blinding procedure 136 
The participants received a dose of 0.3 g·kg-1·day-1 of placebo (dextrose) for 7 days 137 
and, subsequently, creatine monohydrate (Creapure®, AlzChem AG, Germany) for an 138 
additional 7 days. Placebo and creatine supplements were given separately in an envelope 139 
with 7 packages (one package per day) containing the exact daily amount of the supplement. 140 
Participants were instructed to ingest the supplement at breakfast, lunch, dinner and before 141 
bedtime. Creatine and placebo supplements were formulated in indistinguishable tablets with 142 
identical appearance, taste, and smell. The packages were coded so that the participants were 143 
not aware of the contents until completion of the analyses.  144 
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 145 
Muscle and Brain PCr content 146 
 Muscle PCr content was assessed in vivo by 31P-MRS using a whole body 3.0T MRI 147 
scanner (Achieva Intera, Philips, Best, The Netherlands) and a 14 cm diameter 31P surface 148 
coil. In brief, the surface coil was centered on the calf muscle of the left leg. The scanner 149 
body coil was used to obtain conventional anatomical T1-weighted magnetic resonance 150 
images in 3 orthogonal planes. 31P-MRS was acquired using the image selected in vivo 151 
spectroscopy (ISIS) sequence with an echo time and repetition time of 0.62 ms and 4500 ms. 152 
Spectrum bandwidth was 3000 Hz with 2048 data points and 64 repetitions. Before the 153 
intervention, muscle 31P-MRS scans were performed twice on the same day. After the 154 
completion of the first test, the patients were asked to leave the machine and, then, to return 155 
to it for the re-test. The coefficient of variation (CV) was obtained for children (n = 4), adults 156 
(n = 4) and elderly (n = 4) were 14.25%, 6.83%, and 8.63%, respectively.  157 
Brain PCr examination was accomplished using a dual-tune 31P/1H birdcage head coil 158 
(AIRI, Cleveland, OH, U.S.A.). A T1-FFE axial sequence was acquired (TR = 7.6 ms; 159 
TE = 3.7 ms; flip angle = 8°; isotropic 1-mm3 resolution) with reconstructions of the sagittal 160 
and coronal planes. These images were used for the placement of the 31P-MRS voxel centered 161 
in the centrum semiovale. 31P-MRS was acquired using the ISIS sequence with an echo time 162 
and repetition time of 0.096 ms and 6000 ms, respectively. Spectrum bandwidth was 6000 Hz 163 
with 1024 data points and 128 repetitions. Voxel size varied from 95-120 mm in AP, 70-90 164 
mm in LR, and 40-48 mm in CC direction, as shown in Figure 2. Before the intervention, 165 
brain 31P-MRS scans were performed twice as described above for muscle, and the 166 
coefficient of variation (CV) obtained for children (n = 4), adults (n = 4) and elderly (n = 4) 167 
were 9.99%, 5.93%, and 3.80%, respectively.  168 
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Raw spectrum data were analyzed with Java Magnetic Resonance User Interface 169 
(jMRUI) software, and processing steps included apodization to 5Hz, Fourier transform, and 170 
phase correction. The advanced method for accurate, robust, and efficient spectral fitting 171 
(AMARES) algorithm was used to fit the time-domain data (44). Prior knowledge was 172 
established to keep some physical parameters constant or constrained; these parameters 173 
included line-width constraints, chemical shifts, and J-coupling. Zero- and first-order phase 174 
corrections were applied for convergence during the spectral fitting. In addition, for the brain 175 
spectra it was necessary to truncate the first two FID data points, which were discarded to 176 
reduce the baseline distortion effects produced by the broad-line components 177 
(macromolecules). The quality of the fitting was verified by the absence of any residual 178 
signals. The PCr signal was quantified relative to the γ-ATP signal and expressed as PCr/γ-179 
ATP ratio both in brain and in muscle, in order to allow for comparison between tissues.  180 
Due to technical issues, brain MRS exams were lost for 1 child, 1 omnivore, 2 181 
vegetarians, and 1 elderly participant, whereas muscle MRS exams were lost for 4 omnivores, 182 
4 vegetarians, and 5 elderly participants. 183 
 184 
Statistical analysis 185 
Data were tested by two mixed-models with repeated measures using the software 186 
SAS version 9.1. To test the effect of “age”, a 3-factor model was performed, with “age” 187 
(children, omnivorous adults, and elderly), “supplement” (creatine and placebo) and “tissue” 188 
(brain and muscle) as fixed factors. To test the effect of “diet”, a 3-factor model was 189 
conducted, with “diet” (omnivorous and vegetarian adults), “supplement” (creatine and 190 
placebo) and “tissue” (brain and muscle) as fixed factors. In both models, “participants” were 191 
defined as random factors with the Tukey-Kramer adjustment being used for 192 
multicomparison analyses. We also performed a delta analysis (i.e., PCr values in “creatine” 193 
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condition subtracted by PCr values in “placebo” condition), having pre-supplementation PCr 194 
levels (i.e., following the placebo arm) as a co-variable. A post-hoc analysis using 195 
independent samples Student t-test was performed to compare the delta muscle PCr values 196 
between males and females within each group, in order to explore the potential influence of 197 
sex on creatine loading. Data are expressed as mean ± SD, delta scores, and effect size (ES), 198 
unless otherwise stated. The significance level was set at p<0.05. 199 
 200 
RESULTS 201 
 Adult vegetarians showed the lowest creatine intake (p<0.0001 vs. all others). Adult 202 
omnivores had higher creatine intake than children (p=0.0004) and elderly (p<0.0001), with 203 
the latter two groups showing similar creatine consumption (p=0.8118). After body mass 204 
adjustment, creatine intake remained lower in adult vegetarians in comparison to all other 205 
groups (p<0.0001); adult omnivores and children had similar creatine intake (p=0.7393), but 206 
both groups had higher creatine intake than elderly (p<0.0001 for both comparisons). 207 
In all groups, muscle and brain PCr contents were similar between baseline and after 208 
placebo supplementation (i.e., both conditions with no creatine supplementation; p>0.05), 209 
meaning that PCr content was stable and the measures were repeatable. Therefore, to test the 210 
effects of creatine supplementation, all further comparisons will be made between placebo 211 
(i.e., before supplementation) vs. creatine (i.e., after supplementation) conditions. 212 
Figure 3 depicts the influence of age on tissue PCr content in relation to creatine 213 
supplementation. Before creatine supplementation, children had lower muscle PCr content as 214 
compared to omnivorous adults and elderly (p<0.0001 for both), whereas omnivorous adults 215 
and elderly showed similar muscle PCr (p=0.9535). Creatine supplementation increased 216 
muscle PCr in children (p<0.0003) and elderly (p<0.001), whereas the increase in 217 
omnivorous adults did not reach statistical significance (+10.3%, ES: +1.2; p=0.3348). 218 
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Muscle PCr responses to supplementation were better in elderly than in children and 219 
omnivorous adults (p<0.0001 for both), whereas children experienced greater muscle PCr 220 
increases than omnivorous adults (p=0.0022). Muscle PCr content was superior to brain PCr 221 
content, regardless of “age” or “supplement” (p<0.0001 for all comparisons). Furthermore, 222 
creatine supplementation did not elicit any change in brain PCr in all groups (placebo vs. 223 
creatine in children: p=0.8756; in adult omnivores: p=0.9595; in elderly: p=0.7116).   224 
Figure 4 illustrates the influence of diet on tissue PCr content in relation to creatine 225 
supplementation. Omnivores and vegetarians showed similar muscle PCr content before 226 
creatine supplementation (p=0.2448). Following creatine supplementation, vegetarians 227 
(p<0.0001), but not omnivores, had significant increases in muscle PCr content; post-228 
supplementation PCr content was significantly higher in vegetarians than omnivores 229 
(p<0.0001). Muscle PCr content was higher than brain PCr content, irrespective of “diet” and 230 
“supplement” (p<0.0001 for all comparisons). Brain PCr content was not affected by placebo 231 
or creatine supplementation in any group (p>0.05 for all), nor was it significantly different 232 
between omnivores and vegetarians before (p=0.7588) or after supplementation (p=0.6826). 233 
Delta analysis (Figure 5) showed that creatine supplementation promoted greater 234 
increases in muscle PCr in vegetarians and elderly when compared with children (p=0.0204 235 
and p=0.0191, respectively) and omnivores (p=0.0221 and p=0.0212, respectively). Muscle 236 
PCr accretion was comparable between vegetarians and elderly (p=0.8523), and children and 237 
omnivores (p=0.9725). Changes in brain PCr content (-0.7 to +3.9%) were lower than those 238 
observed in muscle PCr content (+10.3 to +27.6%; p<0.0001 for all groups), and did not 239 
differ between children, omnivores, vegetarians and elderly (p>0.05 for all comparisons). Co-240 
variation analysis indicated that pre-supplementation PCr content had no influence upon the 241 
results (p>0.05). In addition, a post-hoc analysis showed no influence of sex on the changes 242 
in PCr accumulation in skeletal muscle following supplementation (boys: 0.62 ± 0.42 vs. 243 
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girls: 0.32 ± 0.41 PCr/ ATP, p = 0.24; omnivorous men: 0.07 ± 0.75 vs. omnivorous women: 244 
0.45 ± 0.56 PCr/ ATP, p = 0.36; vegetarian men: 1.44 ± 0.48 vs. women: -0.21 ± 2.24 PCr/ 245 
ATP, p = 01829; elderly men: 0.60 ± 0.58 vs. women: 0.48 ± 2.14 PCr/ ATP, p = 0.8918).     246 
 247 
DISCUSSION 248 
 In this study, we examined whether a standardized creatine supplementation protocol 249 
(i.e., 0.3 g·kg-1·day-1 for 7 days) leads to differential changes in PCr accumulation according 250 
to age, tissue and diet. The main findings were as follows:  i) age did influence muscle PCr  251 
accretion, since elderly showed greater PCr increases as compared to children and 252 
omnivorous adults; ii) diet did influence muscle PCr accretion, since vegetarians had greater 253 
PCr increases than omnivores; iii) creatine accretion following supplementation did depend 254 
on tissue, since PCr accumulation was greater in muscle than in brain; iv) brain PCr remained 255 
unchanged after creatine supplementation in all groups, suggesting that the classic protocol 256 
designed for muscle loading is not effective to significantly increase PCr in brain; v) brain 257 
PCr content was consistently and markedly lower than muscle PCr content, regardless of age 258 
or diet. Collectively, these data indicate that using a single “universal” protocol, originally 259 
designed for increasing muscle creatine/PCr content in young individuals, may lead to 260 
heterogeneous responses in different populations, since PCr responses were shown to be age-, 261 
tissue- and diet-specific.  262 
 Muscle creatine/PCr content may fluctuate as a function of lifespan. There are studies 263 
showing that muscle creatine/PCr is decreased in older individuals when compared with their 264 
younger counterparts (8, 27, 28, 30, 36), despite some evidence suggesting the opposite (21, 265 
33). This possible age-related reduction in muscle creatine/PCr content has been associated 266 
with differences in i) the distribution of type II fibres, which has slightly greater PCr content 267 
than type I fibres (42); and ii) the consumption of creatine-based food, which is generally 268 
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lower in older than younger individuals (34). To our knowledge, this is the first study 269 
examining PCr responses to creatine supplementation in children, adults and elderly 270 
individuals simultaneously. Our data showed that all these groups are capable of responding 271 
to supplementation with increases in muscle PCr content (main effect of “supplement”), 272 
although the ~10% increase in omnivorous adults did not reach statistical significance, 273 
corroborating previous findings (4, 34). Importantly, elderly individuals reached greater 274 
muscle PCr content than omnivorous adults and children. Likewise, changes in muscle PCr 275 
content (Figure 4) were greater in elderly individuals (% change = +22.7; ES = +2.1) than 276 
children (% change = +13.9; ES = +1.3) and omnivores (% change = 10.3%; ES = +1.2). 277 
These age-related differences could be partially explained by the fact that elderly consumed 278 
half of the dietary creatine (on a weight basis) than their younger peers, even though pre-279 
supplementation muscle PCr content was comparable between groups (the influence of diet 280 
on PCr content is further discussed in the next paragraph). These data shed light on the 281 
unique potential of creatine supplementation in augmenting muscle creatine/PCr content in 282 
older populations, possibly leading to gains in physical capacity and lean mass, which may be 283 
of great therapeutic relevance (13, 14).    284 
 Further to the influence of age on creatine responses, we also showed that diet is a 285 
major factor affecting muscle PCr accumulation following supplementation. As expected, 286 
muscle PCr increases were dramatically superior in vegetarians than in omnivores. Since pre-287 
supplementation PCr content did not statically differ as a function of diet, which is in 288 
agreement with previous data (3), it is possible to speculate that dietary creatine, rather than 289 
baseline PCr content, played an important role in contributing to PCr accumulation in 290 
response to supplementation. These data support the long-standing notion that chronic low-291 
creatine consumers (e.g., vegetarians) may experience greater muscle responses from creatine 292 
supplementation when compared with habitual meat eaters (4, 5, 17). However, it remains 293 
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unclear i) whether short- or mid-term dietary creatine withdrawal could produce better 294 
responses to supplementation; ii) whether dietary creatine is also a factor influencing 295 
creatine/PCr accumulation in children or older individuals; and iii) the molecular mechanisms 296 
by which low dietary creatine leads to increased muscle creatine/PCr accretion (e.g., 297 
regulation of creatine transporter [CreaT] through diet) (47).     298 
 Perhaps the most striking findings from this study was the clear inability of creatine 299 
supplementation to increase brain PCr, as opposed to muscle PCr. Northern blot and 300 
immunohistochemical experiments revealed the presence of the creatine transporter at the 301 
blood-brain-barrier, suggesting that the creatine transporter plays a pivotal role in supplying 302 
creatine to the brain (18, 35). In fact, orally ingested creatine (4-8 g·day-1 over 2 years) was 303 
able to increase brain creatine content in creatine-deficient patients, promoting important 304 
therapeutic effects in this condition (39, 40). However, creatine supplementation seems to be 305 
much less effective in increasing brain creatine content in healthy individuals. For instance, 306 
oral consumption of creatine (20 g·day-1 for 4 weeks) yielded an 8.7% increase in total brain 307 
creatine, with a considerable intersubject variability (3.5 to 13.3%) (6). More recently, we 308 
showed comparable creatine content of the posterior cingulate cortex in vegetarians and 309 
omnivores (52), suggesting that brain may primarily rely on its own creatine synthesis rather 310 
than creatine uptake. This hypothesis is corroborated by in situ hybridization experiments 311 
showing brain mRNA expression of the enzymes involved in creatine synthesis (1). The 312 
findings herein presented also cast doubt on the ability of creatine supplementation to 313 
effectively increase brain creatine/PCr content in healthy individuals, regardless of their age 314 
or dietary patterns. At least, it is safe to conclude that the supplementation protocol employed 315 
in this study, which is able to promote muscle creatine/PCr loading, failed to produce any 316 
increase in brain PCr, indicating that higher-dose and/or longer-duration protocols must be 317 
developed to optimize brain creatine/PCr accumulation.  318 
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This seems to be a critical step in determining the actual role of increased brain 319 
creatine/PCr via supplementation on cognitive function. Importantly, there is evidence that 320 
brain creatine/PCr accumulation following supplementation may vary substantially according 321 
to the brain region assessed (i.e., from 4.7% in gray matter to 14.6% in the thalamus) (6). 322 
Thus, one may argue that studies should employ multi-voxel technologies in an attempt to 323 
identify the most (and the least) responsive brain regions to creatine supplementation, since 324 
this could better predict the brain functions potentially affected by this supplement. In this 325 
respect, however, we recently demonstrated that creatine supplementation at the same dosage 326 
employed in the current study failed to increase creatine concentration of the left dorsolateral 327 
prefrontal cortex, left hippocampus, and occipital lobe in healthy children (29), suggesting an 328 
overall inability of this supplementation protocol to increase brain creatine, at least in this 329 
population. In contrast, creatine supplementation (also the same protocol used in this study) 330 
resulted in a 9% average increase in total creatine in the hand knob of the left precentral 331 
gyrus (sensorimotor cortex) in healthy adults (43).  332 
In fact, the limited number of studies assessing brain creatine/PCr content following 333 
creatine supplementation in healthy individuals have shown only minor changes, if any, in 334 
these substrates (generally inferior to 10%) (6, 25, 29, 31, 43, 49). Given that these studies 335 
have small sample sizes and considerable experimental heterogeneity (e.g., diversified 336 
creatine protocols, studied populations, methods to detect creatine/PCr, brain areas of 337 
interest), it remains uncertain to what extent creatine supplementation increases brain 338 
creatine/PCr content and, more importantly, how this relates to brain functionality. In future, 339 
it is also relevant to identify the characteristics of responders and non-responders to creatine 340 
supplementation with special reference to brain. As our data provide compelling evidence 341 
that diet, which is the major factor influencing creatine/PCr accretion in skeletal muscle 342 
following supplementation (as confirmed in the current study), does not affect brain PCr 343 
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accumulation (at least in the area assessed), one may suggest that factors underlying creatine 344 
responsiveness may be tissue-specific.   345 
 This study is not without its limitations. Firstly, we tested only a single creatine 346 
protocol, hampering any dose-response analyses; further studies should test different 347 
protocols in length and dose to determine the optimal supplementation regime particularly for 348 
brain creatine/PCr loading. Secondly, we measured PCr via 31P-MRS instead of total creatine 349 
via 1H-MRS technique, since the former showed better reliability in our pilot experiments. 350 
While we were not able measure total creatine, PCr itself has been consistently shown to be 351 
highly sensitive in response to creatine supplementation (both in muscle (17) and in brain 352 
(25, 31, 49)), although it remains controversial whether PCr and free creatine increase to the 353 
same extent (2, 7, 11, 12). Thirdly, due to the relatively low number of males and females 354 
participants enrolled in this study, it remains to be confirmed whether PCr accumulation is 355 
not sex-dependent, as suggested by our sub-analysis. Finally, as elderly individuals exhibited 356 
lower dietary creatine intake (on a weight basis) than children and adults, it is impossible to 357 
completely separate the effect of diet and age on PCr responses in this study.    358 
 In conclusion, this comprehensive study showed that PCr responses to a standardized 359 
creatine protocol (i.e., 0.3 g·kg-1·day-1 for 7 days) is affected by age, diet and tissue. While 360 
creatine supplementation was able to increase muscle PCr in all groups, although to different 361 
degrees (i.e., older > younger; vegetarians > omnivores), brain PCr was shown to be 362 
unresponsive. These findings demonstrate the need to tailor specific creatine protocols 363 
capable of optimising creatine/PCr accumulation both in muscle and in brain, enabling a 364 
better appreciation of the pleiotropic properties of creatine, as well as the rational use of 365 
creatine supplements in sports and clinical settings.  366 
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Figure 1. Illustration of the research questions and the studied factors potentially 
affecting PCr responses to creatine supplementation (top) and the experimental design 
(bottom).  
 
 
Abbreviation: 31P-MRS = phosphorus magnetic resonance spectroscopy. Day 0 
represents baseline, day 7 and day 14 represent the end of the placebo and creatine 
arms, respectively.   
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Figure 2. Magnetic resonance images showing the volume of interest (VOI) selected for 
phosphorous spectroscopy at the brain and muscle. For brain, a T1-FFE axial sequence 
was acquired (TR = 7.6 ms; TE = 3.7 ms; flip angle = 8°; isotropic 1-mm3 resolution) 
with reconstructions of the sagittal and coronal planes. These images were used for the 
placement of the 31P-MRS voxel centered in the centrum semiovale. Voxel size varied 
from 95-120 mm in AP, 70-90 mm in LR, and 40-48 mm in CC direction. For muscle, 
the surface coil was centered on the calf muscle of the left leg. The scanner body coil 
was used to obtain conventional anatomical T1-weighted magnetic resonance images in 
3 orthogonal planes.  
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Figure 3. Influence of age on tissue PCr content before and after creatine 
supplementation. 
 
There were significant main effects of “age” (p<0.0001), “supplement” (p<0.0001), and 
“tissue” (p<0.0001), and a significant interaction effect of “age” x “supplement” x 
“tissue” (p=0.0103).  
a, b and c are statistically different from one another 
*denotes a significant within-group effect (i.e., different from placebo) 
$denotes a significant between-group effect (i.e., groups are different before creatine 
supplementation)  
#denotes a significant difference between tissues 
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Figure 4. Influence of diet on tissue PCr content in relation to creatine supplementation. 
 
There were significant main effects of “diet” (p<0.0179), “supplement” (p=0.0003), and 
“tissue” (p<0.0001), and a significant interaction effect of “diet” x “supplement” x 
“tissue” (p=0.0037).  
a, b are statistically different from each other 
*denotes a significant within-group effect (i.e., different from placebo) 
#denotes a significant difference between tissues 
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Figure 5. Delta changes in PCr in response to creatine supplementation (i.e., creatine 
subtracted from placebo values) in muscle and brain. 
 
a, b, c are statistically different from each other 
Abbreviation: ES = effect size.  
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Table 1. Participants’ demographic characteristics.  
Variable Children  (n=15) 
Adults  
Elderly  
(n=18) Omnivores 
(n=17) 
Vegetarians 
(n=14) 
Sex (M / F) 9 / 6 11 / 6 8 / 6 9 / 9 
Age (y) 11.20 ± 0.94a 29.18 ± 7.81b 30.21 ± 6.645b 71.78 ± 6.97c 
BMI (Kg/h²) 17.73 ± 3.06a 25.27 ± 2.83b 23.40 ± 3.21b 26.19 ± 2.92c 
IPAQ  
(Low / Moderate / 
High) 
4 / 1 / 10 6 / 5 / 6 6 / 3 / 5 13 / 4 / 1 
Total energy (Kcal) 
2224.30 ± 
488.57a 
2354.15  ± 
762.30a 
1670.85 ± 
598.14b 
1834.00 ± 
107.44b 
Carbohydrates (g) 321.10 ± 103.73a 290.17  ± 91.97a 238.25 ± 95.05b 235.36 ± 107.87b 
Lipids (g) 67.65 ± 21.34a 84.59  ± 49.64b 49.27 ± 27.12a 58.21 ± 30.16a 
Protein (g) 80.32 ± 28.02a 102.96  ± 53.06a 64.14 ± 36.20b 84.83 ± 3456a 
Protein (g/Kg) 1.60 ± 0.91a 1.40 ± 0.73a,c 0.92 ± 0.48b 1.24 ±0.44b,c 
Dietary creatine (g) 1.03 ± 0.39a 1.73 ± 1.07b 0.01 ± 0.0c 0.92 ± 0.44a 
Dietary creatine 
(g/Kg) 
0.02 ± 0.01a 0.02 ± 0.01a 0.00 ± 0.00b 0.01 ± 0.01c 
Data are mean ± SD. Abbreviations: M=male; F=female; y=years; BMI=body mass 
index; IPAQ=International Physical Activity Questionnaire (short-version); g=grams. 
Different letters mean statistically significant difference between groups (i.e., children, 
omnivore and vegetarian adults, and elderly).    
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